Lupin says VISUfarma acquisition now expected to close by February 28

Lupin had earlier indicated that the transaction of the Amsterdam-based firm would be consummated by the end of the calendar year 2025. Shares of Lupin Ltd ended at ₹2,080.40, down by ₹1.70, or 0.082%, on the BSE today, December 30.

Leave a Reply

Your email address will not be published. Required fields are marked *